Health care is one of the most important issues these days. Everyone wants a good health this time. About their health every body is serious now a day.we knows very well that Health is Wealth. If we lost our health we lost every thing. Good health and fitness has become top level priority for people in all over world. Our medical science always point to the great benefits of regular exercise and managing a healthy diet, many of us have begun follow daily routines designed to make us feel healthier and help us to live longer. These days every body’s health and fitness is going down due to pollution, mediation, work pressure and have a not good daily routine.
Lifecare Innovations Pvt. Ltd. was established on 13th November 2000. As a medical biotechnology company engaged in research, development, manufacturing and marketing of healthcare products, the company specializes in controlled release pharmaceuticals employing an array of technologies of novel drug delivery systems (NDDS).
Lifecare Innovations Pvt. Ltd. is the first Indian company to manufacture a Liposomal drug and second company in the world that manufacture Liposomal Amphotericin B under the brand name FUNGISOME .Imported Liposomal Amphotericin B is very expensive so due to this we should restricting and limiting its use. Lifecare Innovations is very concern to make Liposomal Amphotericin B easily affordable to patients at less payable price in India in addition to tapping the vast export potential.FUNGISOME™ is a life-saving drug used in the treatment of invasive fungal infections and Kala-Azar. Systemic fungal infections frequently and easily occur in recipients of organ transplants, those undergoing dialysis, radiotherapy or chemotherapy for cancer, diabetics and serious burn injuries. Kala-Azar is very popular in Bihar, Orissa, Eastern Uttar Pradesh, Bengal and northeastern states of India.
With the introduction of FUNGISOME™ Lifecare Innovations has made foray in an area few companies in the developed world have gained entry.
Article Directory: http://www.articletrunk.com
Please Rate this Article
Not yet Rated